Cargando…

RORα controls hepatic lipid homeostasis via negative regulation of PPARγ transcriptional network

The retinoic acid receptor-related orphan receptor-α (RORα) is an important regulator of various biological processes, including cerebellum development, circadian rhythm and cancer. Here, we show that hepatic RORα controls lipid homeostasis by negatively regulating transcriptional activity of peroxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyeongkyu, Boo, Kyungjin, Yu, Young Suk, Oh, Se Kyu, Kim, Hyunkyung, Jeon, Yoon, Bhin, Jinhyuk, Hwang, Daehee, Kim, Keun Il, Lee, Jun-Su, Im, Seung-Soon, Yoon, Seul Gi, Kim, Il Yong, Seong, Je Kyung, Lee, Ho, Fang, Sungsoon, Baek, Sung Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534431/
https://www.ncbi.nlm.nih.gov/pubmed/28757615
http://dx.doi.org/10.1038/s41467-017-00215-1
Descripción
Sumario:The retinoic acid receptor-related orphan receptor-α (RORα) is an important regulator of various biological processes, including cerebellum development, circadian rhythm and cancer. Here, we show that hepatic RORα controls lipid homeostasis by negatively regulating transcriptional activity of peroxisome proliferators-activated receptor-γ (PPARγ) that mediates hepatic lipid metabolism. Liver-specific Rorα-deficient mice develop hepatic steatosis, obesity and insulin resistance when challenged with a high-fat diet (HFD). Global transcriptome analysis reveals that liver-specific deletion of Rorα leads to the dysregulation of PPARγ signaling and increases hepatic glucose and lipid metabolism. RORα specifically binds and recruits histone deacetylase 3 (HDAC3) to PPARγ target promoters for the transcriptional repression of PPARγ. PPARγ antagonism restores metabolic homeostasis in HFD-fed liver-specific Rorα deficient mice. Our data indicate that RORα has a pivotal role in the regulation of hepatic lipid homeostasis. Therapeutic strategies designed to modulate RORα activity may be beneficial for the treatment of metabolic disorders.